GUANGZHOU, China, Sept. 9, 2019 /PRNewswire/ -- On August 28-29, the BBS & Excellent Product Award Ceremony for Reducing Antibiotic Resistance for the Layer Industry was held in Guangzhou.China's Ministry of Agriculture and Rural Affairs reiterat

SAN MARCOS, Calif., Sept. 9, 2019 /PRNewswire/ -- Nutricare, a Certified B Corp, has been recognized as Best For The World honoree in recognition of its sustainability movement and environmental achievements in business.

GUANGZHOU, China, Sept. 9, 2019 /PRNewswire/ -- The three organisers of the leading beauty exhibitions, i.e., BolognaFiere, Informa Markets and Shanghai Baiwen Exhibition Co Ltd have joined hands to host South China Beauty Expo in the Shenzhen Convention & Exhibition Center from July 30 to August 1, 2020

NEW YORK, Sept. 9, 2019 /PRNewswire/ -- Suicide prevention among young people is a growing concern across the country.  According to the National Youth Risk Behavior Survey (YRBS), 31.5 percent of American high school students reported experiencing persistent feelings of sadness or hopelessness, and 17.2 percent reported they have seriously considered attemptin

INDIANAPOLIS, Sept. 9, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today presented data from the LIBRETTO-001 clinical trial intended to support the registration of oral selpercatinib[1] monotherapy, also known as LOXO-292, for the treatment of RET fusion-positive non-small cell lung cancer (NSCLC). In the registration dataset consisting of t

CARLSBAD, Calif., Sept. 9, 2019 /PRNewswire/ -- Thermo Fisher Scientific today announced an agreement with Eli Lilly and Company for development of a companion diagnostic that will use the U.S Food and Drug Administration-approved, next-generation sequencing-based Oncomine Dx Target Test to identify certain non-small cell lung cancer (NSCLC) and thyroid cancer patients w

AMSTERDAM, Sept. 9, 2019 /PRNewswire/ -- SpePharm AG, a subsidiary of Norgine B.V., announced that the United States District Court for the District of Delaware ruled on 4th September 2019 in favour of SpePharm in its proceeding against Eisai Inc., upholding SpePharm's licensed rights for SALAGEN®

SAN JOSE, Calif., Sept. 8, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced today that Vu Truong, Ph.D., Chief Executive Officer, will present at the H.

WALTHAM, Mass., Sept. 8, 2019 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA) — the nation's leading renal care company – and the

THOUSAND OAKS, Calif., Sept. 8, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data from the ongoing Phase 1 study evaluating AMG 510 in patients with previously treated KRAS G12C-mutated solid tumors. AMG 510 is a first-in-class investigational oral therapy that is designed to selectively and irreversibly target the KRASG12C protein.